Value of Medicines
A collection of papers demonstrating the impact of medicines on public health and the economy.
- The Value of Medicines in Offsetting Healthcare Costs  NEW (PDF)
- Value of Medicines for Metastatic Breast Cancer (PDF)
- Value of Medicines for Healthy Aging  (PDF)
- Value of Medicines for Stroke & Atrial Fibrillation  (PDF)
- Value of Rheumatoid Arthritis Treatment  (PDF)
- Value of Vaccines  (PDF)
- Value of Over-the-Counter Medicines  (PDF)
- Value of Targeted Therapies in Kidney Cancer  (PDF)
- Value of Medicines for Smoking Cessation  (PDF)
- Value of Medicines for Type 2 Diabetes  (PDF)
- Value of Drug Adherence  (PDF)
- Value of Oncology Medicines  (PDF)
- Value of Statins  (PDF)
Future Topics in Development:
- Papers will soon be available demonstrating value in a variety of areas including Rare Diseases, Pain and more. Stay tuned!
Pfizer has long maintained that medicines provide tremendous value to individuals and society as a whole. We have now captured that value in a series of concise, easy-to-access papers that detail the societal and economic value provided by medicines that treat various disease areas. The data we provide come from published, peer-reviewed studies and are complemented by real stories from patients who have benefited from medicines. We hope these will serve as a resource to those looking to quantify the value of medicines.
Jack Watters, Vice President of External Medical Affairs, discusses Pfizer’s Value of Medicines  campaign with the National Association of Chain Drug Stores (NACDS). Click here to read the full interview .
Pfizer's "Value of Medicines" papers outline the social health and economic value of a variety of classes of treatments. The supporting 90-second videos below illustrate the positive impact that medicines have had on two patients, Matt Woods and Jack Whelan. Both faced life-threatening health conditions. Their stories provide insights into the important role that medicines have played in their respective journeys towards improved health.
Select Infographics from these papers:
From Value of Oncology Medicines: 5-Year Relative Survival Rates for Cancers in US2
From Value of Drug Adherence: Return on Investment from Improved Medication Adherence: Diabetes3
History of Development: Targeted Treatment Options for Advanced RCC
Thirty-three percent of all smoking-related deaths are from cardiovascular diseases
Total Cost of Diagnosed Diabetes in the US 2007–2012
Smokers in the USA
World Cigarette Consumption
From Value of Statins: Societal Health Impact1
1 See Value of Statins  for multiple references
2 National Cancer Institute, Survival Epidemiology and End Results (SEER), posted to website, viewed at http://seer.cancer.gov/csr/1975_2005/accessible_contents.html  in September, 2013.
3 Adopted from: M. Sokol et al., “Impact of Medication Adherence on Hospitalization Risk and Healthcare Cost,” Journal of Medical Care, 2005. Notes: Adherence is the extent to which patients take medicines as prescribed, in terms of dose and duration. Return on Investment estimates reflect spending attributable to the condition listed.